Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation

Cardiovasc Res. 1986 Jul;20(7):536-41. doi: 10.1093/cvr/20.7.536.

Abstract

The effects of L-propionylcarnitine on the recovery of cardiac contractile performance after global ischaemia and reperfusion were studied in isolated perfused rat hearts. The addition of either 5.5 or 11 mmol X litre-1 L-propionylcarnitine significantly improved the recovery of cardiac output, left ventricular pressure, and dP/dt after 90 min of ischaemia and 15 min of reperfusion. Myocardial adenosine triphosphate and creatine phosphate concentrations were significantly higher in the L-propionylcarnitine treated hearts than in controls, but the concentrations of long chain acyl carnitine and coenzyme A were unaffected. The protecting effects of L-propionylcarnitine were compared with those of L-carnitine and L-acetylcarnitine. A 11 mmol X litre-1 dose of L-propionylcarnitine and L-acetylcarnitine significantly improved the recovery of cardiac output after 90 min of ischaemia and 15 min of reperfusion, but L-carnitine did not. L-Propionylcarnitine was the most protective agent. The effects of these derivatives on L-3H-carnitine transport and 14C-palmitate oxidation were also measured. All of these derivatives competitively inhibited L-3H-carnitine transport in isolated cardiac myocytes, but L-propionylcarnitine was the most potent. Carnitine and L-propionylcarnitine stimulated palmitate oxidation in the homogenate, whereas L-acetylcarnitine inhibited it. In myocytes only L-propionylcarnitine affected palmitate oxidation. These data show that L-propionylcarnitine protects the ischaemic myocardium. Its protection is greater than that for L-carnitine or L-acetylcarnitine, and the difference in effectiveness may relate to the rate of transport into the cells and the effects on fatty acid utilisation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcarnitine / pharmacology
  • Adenosine Triphosphate / metabolism
  • Animals
  • Blood Pressure / drug effects
  • Cardiac Output / drug effects*
  • Carnitine / analogs & derivatives*
  • Carnitine / metabolism*
  • Carnitine / pharmacology
  • Coronary Disease / metabolism
  • Coronary Disease / physiopathology*
  • Fatty Acids / metabolism*
  • Male
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism*
  • Oxidation-Reduction / drug effects
  • Palmitic Acid
  • Palmitic Acids / metabolism
  • Phosphocreatine / analysis
  • Rats
  • Rats, Inbred Strains

Substances

  • Fatty Acids
  • Palmitic Acids
  • Phosphocreatine
  • propionylcarnitine
  • Palmitic Acid
  • Acetylcarnitine
  • Adenosine Triphosphate
  • Carnitine